LUMBY, BC, Sept. 30 /PRNewswire-FirstCall/ -- avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced a recent conference call with StocksHaven Investments has been released on StocksHaven.com. The conference call was held on September 29, 2009, and covered a range of topics including avVaa's financial status, revenue projections, upcoming products, and ongoing business operations. The call featured avVaa co-founders Jack Farley, CEO and Lorie Campbell-Farley, President speaking with StocksHaven Founder and Lead Investment Analyst Michael Vlaicu. StocksHaven.com announced the conference call on September 20, 2009, and invited interested parties to submit questions, some of which were used during the call. "Mr. Vlaicu was not afraid to ask tough questions," commented Jack Farley, CEO. "But avVaa's recent strong successes and upcoming DRTV media test make the company a pleasure to talk about." avVaa World Health Care Products Inc. is currently preparing to launch its second DRTV media test for Neuroskin(R) Psoriasis Relief. "The call gave us the opportunity to feature Neuroskin(R) Psoriasis Relief, and the full Neuroskin(R) line of products," said Jack Farley. "Many investors are unaware of the full range of Neuroskin(R) products we plan to launch, and of the DermaLustre(R) line we have for animals." The full range of Neuroskin(R) and DermaLustre(R) products can be found on http://www.avvaa.com/. Neuroskin Psoriasis Relief can be purchased from http://www.myneuroskin.com/. The conference call can be heard on http://www.stockshaven.com/conference-call-avvaa-world-health-care-products-in c/. About StocksHaven Investments StocksHaven.com is a website which hosts services for StocksHaven Investments. The website contains a blog, free level 2 quotes, stock research reports, conference calls, news feeds, mass e-mail distribution alerts, videos, stock commentaries, company profiling and other unique content including expert stock analysis from Mr. Michael Vlaicu. The company also obtains and engages in investor relations contracts. About avVaa World Health Care Products avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: http://www.avvaa.com/. Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition. CONTACT: avVaa World Health Care Products Jack Farley, Chairman/CEO Lorie Campbell-Farley, President/COO Investor Relations: Merle Goertz (West Coast) 1-604-688-2349 DATASOURCE: avVaa World Health Care Products CONTACT: avVaa World Health Care Products, Jack Farley, Chairman, CEO, ; Lorie Campbell-Farley, President, COO, ; Investor Relations: Merle Goertz (West Coast), (604) 688-2349

Copyright